Document ID: chunk:federal_register_of_legislation:F2018C00196:reg:9:p2
Version: federal_register_of_legislation:F2018C00196
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 8830–10293

ovary;
(9)          applying talc to the perineal area on more days than not, for a period of at least five years, before the clinical onset of malignant neoplasm of the ovary;
(10)      for epithelial ovarian cancer only:
(a)          being nulliparous at the time of the clinical onset of malignant neoplasm of the ovary; or
Note: nulliparous is defined in the Schedule 1 - Dictionary.
(b)          having hormone replacement therapy for at least five consecutive years before the clinical onset of malignant neoplasm of the ovary, and where the use of hormone replacement therapy has ceased, the clinical onset of malignant neoplasm of the ovary has occurred within ten years of that period;
Note: hormone replacement therapy is defined in the Schedule 1 - Dictionary.
(11)      for mucinous ovarian tumours only, smoking at least five pack-years of cigarettes, or the equivalent thereof in other tobacco products, before the clinical onset of malignant neoplasm of the ovary, and:
(a)          smoking commenced at least ten years before the clinical onset of malignant neoplasm of the ovary; and
(b)          where smoking has ceased, the clinical onset of malignant neoplasm of the ovary, has occurred within 30 years of cessation;
Note: pack-years of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.
(12)      inability to obtain appropriate clinical management for malignant neoplasm of the ovary.